Study Finds Postmenopausal Women Lose More Weight With Both Semaglutide and HRT Women undergoing both treatments also saw improvements in cardiometabolic risk factors It seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss treatment
Because obesity often overlaps with liver disease, cardiovascular risk, and insulin resistance, the safest approach is personalized assessment rather than self-prescribing based on online trends
TB-500 promotes systemic healing, tissue growth, and improved flexibility
Bosello S, De Santis M, Lama G, et al
Chembiochem (2022) 23(10):e202100641
Known by the brand name Ozempic and Wegovy, this once-weekly injectable works with your body to help you achieve sustainable weight loss, complementing lifestyle changes for a healthier, more confident you